Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia

首次发布于 2022 年 6 月 6 日

Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer

首次发布于 2015 年 1 月 14 日

Impact of CASP3 Gene in Chemoresistance

计划入组 60 人 · 首次发布于 2024 年 1 月 8 日

Neuroblastoma (AbelZeta Pharma)

IRP-101

SE486-11

Ferroptosis-Inducing Drug Auranofin Shows Promise in Combination with Chemotherapy for Resistant Neuroblastoma

Naxitamab Shows Promising Results in Treating Relapsed/Refractory High-Risk Neuroblastoma

Australia Approves IFINWIL (Eflornithine) for High-Risk Neuroblastoma Treatment